Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price
₹2,496.30
Market cap
₹1,03,108 Cr
Revenue (annual)
₹14,278 Cr
Net profit (annual)
₹1,913 Cr
P/E (TTM)
50.5×Sector 47.4×
Promoter holding
72.63%-0.03% QoQ
FII holding
9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:10 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma announced that members of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), approved its voluntary liquidation in an EGM.

16:38 IST BSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma's board approved the voluntary liquidation of its subsidiary, Bharat Serums and Vaccines Limited, to integrate its business into the parent company.

21:37 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring Worth ₹55.06 Cr

Mankind Pharma has incorporated a wholly-owned subsidiary in the Netherlands, "Mankind Pharma (Netherlands) B.V.", with an issued capital of ₹55.06 Crore.

Value
₹55.06 Cr
21:28 IST BSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma has incorporated a wholly-owned subsidiary, 'Mankind Pharma (Netherlands) B.V.', in the Netherlands as previously disclosed.

18:14 IST BSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring Worth ₹49 Cr

Mankind Pharma has completed the sale of its 100% stake in Broadway Hospitality Services Private Limited for a cash consideration of ₹ 49 Crore.

Value
₹49.00 Cr
13:56 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring Worth ₹49 Cr

Mankind Pharma will sell its subsidiary Broadway Hospitality Services to AKRK Projects for ₹49 Crore. The cash deal is expected to conclude by October 2026.

Value
₹49.00 Cr
Execution
Expected completion by 2026-10-09
13:54 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring Worth ₹54 Cr

Mankind Pharma will incorporate a wholly-owned subsidiary in Netherlands with a 54 Crore investment. The entity will hold R&D assets and pursue niche therapy joint ventures.

Value
₹54.00 Cr
13:23 IST BSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring Worth ₹103 Cr

Mankind Pharma approved divesting 100% stake in Broadway Hospitality for Rs. 49 Crore. It also plans to invest €5 Million to incorporate a new Netherlands-based subsidiary.

Value
₹103.0 Cr
Execution
90 days